Delivery Order SPE2DR25D6028-SPE2DR26FASYJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,024.20 to AmerisourceBergen Drug Corp for the supply of Quviviq 25 mg tablets (30-count package) under a firm fixed-price contract type. This delivery order, issued on October 22, 2025, represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Quviviq 25 mg tablets (30-count) valued at $1,640.70 on November 13, 2025, with completion scheduled for November 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Quviviq 25 mg tablets in a quantity of 30s. This is a firm fixed price delivery order with a ceiling value of $1,662.22, representing a non-set-aside competitive award. The contract has an ultimate completion date of November 5, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,283.67 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. QUVIVIQ is a prescription medication used in the treatment of insomnia, representing...
- The Defense Logistics Agency awarded a delivery order valued at $1,181.80 to AmerisourceBergen Drug Corp for QUVIVIQ 50 mg tablets (30-count packaging) on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and represents a pediatric insomnia treatment supply to support federal medical procurement needs. The contract performance will be executed from the contractor's Corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,073.34 to AmerisourceBergen Drug Corp for the supply of QUVIVIQ 25 mg tablets (30-count package), a pharmaceutical product used in the treatment of insomnia. This firm fixed-price delivery order, issued on November 14, 2025, is scheduled for completion by November 17, 2025, and will be delivered to a location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a $3,846.82 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 50 mg tablets (30-count) on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Quviviq 50mg tablets (30-count) under a firm fixed price contract valued at $2,466.80. This is a non-set-aside delivery order with an ultimate completion date of December 18, 2025, to be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $215.06 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 25 mg Quviviq tablets. As the prime contractor, Amerisourcebergen Drug will deliver 30 tablets to a location in Conshohocken, Pennsylvania under a one day period of performance from August 15 to August 16, 2023. The Defense Logistics Agency utilizes indefinite delivery vehicle contracts to support medical supply needs for the Department...
- The Defense Logistics Agency awarded a $123,140 delivery order to Amerisourcebergen Drug Corporation for 25mg Quviviq tablets. The firm fixed price order is for 30 boxes of the medication and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania by August 28, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the global supply chain for the U.S. military and this order for a sleep disorder medication is likely in...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASYJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,850.10 to supply Quviviq 50mg tablets (30-count) on December 19, 2025, with completion scheduled for December 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Quviviq is a prescription medication used for insomnia treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, leverages this comprehensive global pharmaceutical support vehicle to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations, the U.S. Coast Guard, and other federal healthcare systems worldwide. The company's consistent receipt of non-set-aside, competitively awarded contracts demonstrates its established capability to meet federal procurement requirements for medical supply delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/18/25 |